Abstract

BackgroundMultimorbidity is becoming increasingly prevalent and presents challenges for healthcare providers and systems. Studies examining the relationship between multimorbidity and quality of care report mixed findings. The purpose of this study was to investigate quality of care for people with multimorbidity in the publicly funded healthcare system in Denmark.MethodsTo investigate the quality of care for people with multimorbidity different groups of clinicians from the hospital, general practice and the municipality reviewed records from 23 persons with multimorbidity and discussed them in three focus groups. Before each focus group, clinicians were asked to review patients’ medical records and assess their care by responding to a questionnaire. Medical records from 2013 from hospitals, general practice, and health centers in the local municipality were collected and linked for the 23 patients. Further, two clinical pharmacologists reviewed the appropriateness of medications listed in patient records.ResultsThe review of the patients’ records conducted by three groups of clinicians revealed that around half of the patients received adequate care for the single condition which prompted the episode of care such as a hospitalization, a visit to an outpatient clinic or the general practitioner. Further, the care provided to approximately two-thirds of the patients did not take comorbidities into account and insufficiently addressed more diffuse symptoms or problems. The review of the medication lists revealed that the majority of the medication lists contained inappropriate medications and that there were incongruity in medication listed in the primary and secondary care sector. Several barriers for providing high quality care were identified. These included relative short consultation times in general practice and outpatient clinics, lack of care coordinators, and lack of shared IT-system proving an overview of the treatment.ConclusionsOur findings reveal quality of care deficiencies for people with multimorbidity. Suggestions for care improvement for people with multimorbidity includes formally assigned responsibility for care coordination, a change in the financial incentive structure towards a system rewarding high quality care and care focusing on prevention of disease exacerbation, as well as implementing shared medical record systems.

Highlights

  • Multimorbidity is becoming increasingly prevalent and presents challenges for healthcare providers and systems

  • The appropriateness of the medications of the patients was reviewed by clinical pharmacologists using the Screening Tool to Alert doctors to Right Treatment and Screening Tool of Older Persons’ potentially inappropriate Prescriptions (START-STOPP criteria) and the Medication Appropriateness Index (MAI) [16,17,18]

  • In general, reviewing clinicians assessed that approximately 50% of patients received adequate treatment for the single condition that prompted an episode of care such as a hospitalization, a visit to an outpatient clinic or the general practitioner

Read more

Summary

Introduction

Multimorbidity is becoming increasingly prevalent and presents challenges for healthcare providers and systems. Studies examining the relationship between multimorbidity and quality of care report mixed findings. The purpose of this study was to investigate quality of care for people with multimorbidity in the publicly funded healthcare system in Denmark. Multimorbidity affects quality of life, ability to work, disability, mortality, and processes of care and has a significant impact on healthcare utilization and costs [6]. The relationship between multimorbidity and quality of care has been examined in recent years. Quality of care for patients with multimorbidity is most appropriately measured by processes, rather than outcomes [7]. Several studies have documented quality of care deficiencies when patients have discordant or unrelated comorbidities [12]. Treatment for multimorbidity often requires multiple condition-specific medications, resulting in polypharmacy and attendant risks [12,13,14,15]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call